×
S&P 500   3,748.66 (-2.00%)
DOW   30,422.21 (-2.17%)
QQQ   279.44 (-0.95%)
AAPL   138.55 (-0.27%)
MSFT   256.41 (-1.22%)
META   161.52 (+0.93%)
GOOGL   2,174.00 (-0.03%)
AMZN   110.20 (+0.58%)
TSLA   663.61 (-2.67%)
NVDA   145.10 (-0.09%)
NIO   21.30 (-0.28%)
BABA   114.80 (-1.03%)
AMD   73.29 (-0.52%)
MU   54.53 (+1.64%)
CGC   2.67 (-4.98%)
T   20.82 (-2.30%)
GE   60.85 (-4.23%)
F   10.84 (-4.24%)
DIS   94.12 (-2.10%)
AMC   12.82 (-5.25%)
PFE   50.65 (-3.17%)
PYPL   71.71 (+0.43%)
NFLX   178.58 (-0.76%)
S&P 500   3,748.66 (-2.00%)
DOW   30,422.21 (-2.17%)
QQQ   279.44 (-0.95%)
AAPL   138.55 (-0.27%)
MSFT   256.41 (-1.22%)
META   161.52 (+0.93%)
GOOGL   2,174.00 (-0.03%)
AMZN   110.20 (+0.58%)
TSLA   663.61 (-2.67%)
NVDA   145.10 (-0.09%)
NIO   21.30 (-0.28%)
BABA   114.80 (-1.03%)
AMD   73.29 (-0.52%)
MU   54.53 (+1.64%)
CGC   2.67 (-4.98%)
T   20.82 (-2.30%)
GE   60.85 (-4.23%)
F   10.84 (-4.24%)
DIS   94.12 (-2.10%)
AMC   12.82 (-5.25%)
PFE   50.65 (-3.17%)
PYPL   71.71 (+0.43%)
NFLX   178.58 (-0.76%)
S&P 500   3,748.66 (-2.00%)
DOW   30,422.21 (-2.17%)
QQQ   279.44 (-0.95%)
AAPL   138.55 (-0.27%)
MSFT   256.41 (-1.22%)
META   161.52 (+0.93%)
GOOGL   2,174.00 (-0.03%)
AMZN   110.20 (+0.58%)
TSLA   663.61 (-2.67%)
NVDA   145.10 (-0.09%)
NIO   21.30 (-0.28%)
BABA   114.80 (-1.03%)
AMD   73.29 (-0.52%)
MU   54.53 (+1.64%)
CGC   2.67 (-4.98%)
T   20.82 (-2.30%)
GE   60.85 (-4.23%)
F   10.84 (-4.24%)
DIS   94.12 (-2.10%)
AMC   12.82 (-5.25%)
PFE   50.65 (-3.17%)
PYPL   71.71 (+0.43%)
NFLX   178.58 (-0.76%)
S&P 500   3,748.66 (-2.00%)
DOW   30,422.21 (-2.17%)
QQQ   279.44 (-0.95%)
AAPL   138.55 (-0.27%)
MSFT   256.41 (-1.22%)
META   161.52 (+0.93%)
GOOGL   2,174.00 (-0.03%)
AMZN   110.20 (+0.58%)
TSLA   663.61 (-2.67%)
NVDA   145.10 (-0.09%)
NIO   21.30 (-0.28%)
BABA   114.80 (-1.03%)
AMD   73.29 (-0.52%)
MU   54.53 (+1.64%)
CGC   2.67 (-4.98%)
T   20.82 (-2.30%)
GE   60.85 (-4.23%)
F   10.84 (-4.24%)
DIS   94.12 (-2.10%)
AMC   12.82 (-5.25%)
PFE   50.65 (-3.17%)
PYPL   71.71 (+0.43%)
NFLX   178.58 (-0.76%)
TSE:HEXO

HEXO Stock Forecast, Price & News

C$0.26
-0.01 (-1.85%)
(As of 07/5/2022 11:13 AM ET)
Add
Compare
Today's Range
C$0.26
C$0.27
50-Day Range
C$0.26
C$0.52
52-Week Range
C$0.25
C$6.94
Volume
324,342 shs
Average Volume
2.54 million shs
Market Capitalization
C$132.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$0.81

HEXO MarketRank™ Forecast

Analyst Rating
Hold
1.86 Rating Score
Upside/​Downside
201.1% Upside
C$0.81 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.27mentions of HEXO in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.31 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive HEXO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter.

HEXO logo

About HEXO (TSE:HEXO) Stock

HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.

HEXO Stock News Headlines

HEXO Remains a Sell at 20 Cents - InvestorPlace
HEXO (TSE:HEXO) Downgraded by Canaccord Genuity Group
HEXO (TSE:HEXO) Shares Down 7.1%
HEXO Launches New At-the-Market Offering
Canadian pot producer Hexo names new CEO
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$0.81
High Stock Price Forecast
C$2.00
Low Stock Price Forecast
C$0.25
Forecasted Upside/Downside
+206.7%
Consensus Rating
Hold
Rating Score (0-4)
1.85714285714286
Research Coverage
7 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$187.28 million
Cash Flow
C$0.03 per share
Book Value
C$0.81 per share

Miscellaneous

Free Float
N/A
Market Cap
C$132.73 million
Optionable
Optionable
Beta
N/A














HEXO Frequently Asked Questions

Should I buy or sell HEXO stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last twelve months. There are currently 1 sell rating and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HEXO stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HEXO, but not buy additional shares or sell existing shares.
View analyst ratings for HEXO
or view top-rated stocks.

What is HEXO's stock price forecast for 2022?

7 analysts have issued 1 year price targets for HEXO's stock. Their HEXO stock forecasts range from C$0.25 to C$2.00. On average, they expect HEXO's share price to reach C$0.81 in the next year. This suggests a possible upside of 206.7% from the stock's current price.
View analysts' price targets for HEXO
or view top-rated stocks among Wall Street analysts.

How has HEXO's stock price performed in 2022?

HEXO's stock was trading at C$0.88 at the beginning of 2022. Since then, HEXO shares have decreased by 69.9% and is now trading at C$0.27.
View the best growth stocks for 2022 here
.

Who are HEXO's key executives?

HEXO's management team includes the following people:
  • Mr. Roch Vaillancourt, Gen. Counsel
  • Mr. Charlie Bowman, Acting Pres & CEO
  • Mr. Julius Ivancsits, Acting Chief Financial Officer
  • Jennifer Smith, Mang. of Financial Reporting & Investor Relations
  • Mr. Max Cyr, Director of Customer Experience & Compliance
  • Ms. Isabelle Dominique Robillard, VP of Communication
  • Ms. Sonia Isabel, Vice-Pres of Sales
  • Mr. Guillaume Jouet, Chief People & Culture Officer
  • Mr. Michael P. Monahan, Consultant (Age 50)
  • Taras Korec, Sr. VP of Procurement

What other stocks do shareholders of HEXO own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), (CGC), Aphria (APHA), Canopy Growth (WEED), Tilray (TLRY), Alibaba Group (BABA), Green Organic Dutchman (TGOD), Curaleaf (CURLF) and (APHA).

What is HEXO's stock symbol?

HEXO trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HEXO."

How do I buy shares of HEXO?

Shares of HEXO and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is HEXO's stock price today?

One share of HEXO stock can currently be purchased for approximately C$0.27.

How much money does HEXO make?

HEXO (TSE:HEXO) has a market capitalization of C$132.73 million and generates C$187.28 million in revenue each year.

How many employees does HEXO have?

HEXO employs 2,021 workers across the globe.

How can I contact HEXO?

HEXO's mailing address is 3000 Solandt Road, Ottawa, Ontario K2K 2X2. The official website for HEXO is hexo.com. The company can be reached via phone at 844-406-1852.

This page (TSE:HEXO) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.